Processing, Please wait...

  • Publisher Home
  • Home
  • 🔙 Back
  • 📚 Journals
    • ⚙️ IJIEC - Industrial Engineering Computations
    • 🌐 IJDNS - Data and Network Science
    • 🧪 CCL - Current Chemistry Letters
    • 💹 AC - Accounting
    • 🎯 DSL - Decision Science Letters
    • 🚛 USCM - Uncertain Supply Chain Management
    • 🏗️ JPM - Journal of Project Management
    • 🏥 HE - Healthcare Engineering
    • 📈 SCI - Scientometrica
    • 🔩 ESM - Engineering Solid Mechanics
    • 🌿 JFS - Journal of Future Sustainability
    • 💼 MSL - Management Science Letters
  • 📝 Submit Article
  • 📊 Statistics
  • 📋 About
    • 📄 About Us
    • 📰 Blog
    • 📢 News
    • 📧 Contact
  • 📺 Tutorial
  • Search:
  • Advanced Search

Growing Science » Authors » Rachida Ghailan

⭐ Highly Cited Articles

  • Jaya Algorithm
  • Rao Algorithm
  • TLBO Algorithm
  • ChatGPT and Blended Learning

Journals

  • IJIEC (840)
  • IJDS (1032)
  • DSL (759)
  • ESM (434)
  • CCL (563)
  • JPM (350)
  • AC (572)
  • JFS (106)
  • MSL (2658)
  • USCM (1104)
  • HE (56)
  • SCI (53)

🔑 Keywords

Jordan(175)
Supply chain management(172)
Vietnam(154)
Customer satisfaction(124)
Performance(117)
Supply chain(115)
Artificial intelligence(108)
Service quality(101)
Competitive advantage(100)
SMEs(95)
Tehran Stock Exchange(94)
Sustainability(94)
optimization(88)
Financial performance(86)
TOPSIS(85)
Trust(85)
Organizational performance(81)
Job satisfaction(81)
Genetic Algorithm(81)
Social media(80)


» Show all keywords

✍️ Authors

Naser Azad(82)
Zeplin Jiwa Husada Tarigan(70)
Mohammad Reza Iravani(65)
Endri Endri(45)
Hotlan Siagian(43)
Muhammad Alshurideh(42)
Dmaithan Almajali(39)
Jumadil Saputra(37)
Muhammad Turki Alshurideh(35)
Ahmad Makui(33)
Sautma Ronni Basana(33)
Barween Al Kurdi(32)
Basrowi Basrowi(31)
Mohammad Khodaei Valahzaghard(30)
Haitham M. Alzoubi(30)
Ni Nyoman Kerti Yasa(30)
Hassan Ghodrati(30)
Shankar Chakraborty(29)
Sulieman Ibraheem Shelash Al-Hawary(28)
Mahmoud Allahham(28)


» Show all authors

🌍 Countries

1. Algeria (52)
2. Angola (2)
3. Argentina (22)
4. Armenia (2)
5. Australia (52)
6. Austria (2)
7. Bahrain (26)
8. Bangladesh (58)
9. Belarus (4)
10. Belgium (3)
11. Benin (2)
12. Benin Republic (1)
13. Bhutan (1)
14. Bosnia and Herzegovina (1)
15. Botswana (9)
16. Brazil (40)
17. Brunei (1)
18. Bulgaria (1)
19. Burkina Faso (1)
20. Cameroon (1)
Total: 121 countries

Show all countries
Sort articles by: 📖 Volume | 📅 Date | ⭐ Most Rates | 👁️ Most Views | 🚀 Rising Stars | 🔗 Citations (Scopus) | 🔥 Hot Papers
1.

Mechanistic and stereoelectronic insights into the asymmetric diels–alder (4+2) cycloaddition toward cantharidin derivatives via DFT: Computational elucidation of their anticancer potential through docking, ADMET, and molecular dynamics analysis Pages 17-34 PDF Download PDF

Authors: Tarik Boutadghart, Khadija Zaki, Youssef Merroun, Abdelouahid Sbai, Rachida Ghailan

doi 10.5267/j.ccl.2025.11.004

🔑 Keywords: DFT, Norcantharimide, Blood Cancer, Molecular docking, ADMET, Molecular dynamics

Abstract:
This investigation employs Molecular Electron Density Theory (MEDT) to elucidate the stereoselective (4+2) cycloaddition between 1-(furan-2-yl)propan-1-one and 1-R-1H-pyrrole-2,5-dione, combining mechanistic and pharmacological analyses. DFT calculations at the M06/6-311++G(d,p) level identified six distinct reaction pathways, revealing the exo cycloadduct as the thermodynamically favored product, consistent with experimental observations. Transition state analysis through NCI revealed stabilizing CH-π and van der Waals interactions governing the exo preference. Beyond mechanistic insights, the derived norcantharimide analogues exhibit promising anticancer potential, with strong binding affinities against hematological malignancy targets. SwissADME profiling confirmed optimal drug-likeness (QED > 0.6, TPSA < 100 Ų) and low hepatotoxicity risk. Notably, molecular dynamics simulations established exceptional stability for lead compound P2d (RMSD 75%) to key catalytic residues. These integrated computational results position these derivatives as viable candidates for blood cancer therapeutics, merging rigorous mechanistic understanding with preclinical potential assessment.
Details
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5

Journal: CCL | Year: 2026 | Volume: 15 | Issue: 1 | Views: 507

 

® 2010-2026 GrowingScience.Com